Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_assertion type Assertion NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_head.
- NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_assertion description "[The results demonstrate that patients with cGVHD had a higher incidence of HP 2-2 phenotype (43.8%), in comparison to the patients without cGVHD (0%) and normal donors (18.7%), suggesting the possibility that specific Hp polymorphism may play a role in the development of cGVHD after allo-HCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_provenance.
- NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_assertion evidence source_evidence_literature NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_provenance.
- NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_assertion SIO_000772 19379511 NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_provenance.
- NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_assertion wasDerivedFrom befree-20140225 NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_provenance.
- NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_assertion wasGeneratedBy ECO_0000203 NP329160.RAEUr6rFXWsIhkVUyq5UivEck6yPtXwHANSIbcxavJK5Q130_provenance.